Related Experiment Video
Updated: Sep 8, 2026

An Injury Paradigm to Investigate Central Nervous System Repair in Drosophila
Published on: March 28, 2013
Nervous System Integrity in Drosophila: Essential and Dosage-Sensitive Roles of Hsp110
Beatriz Rios1,2, Shiyu Xu1, Stephen M Farmer1,2,3
1Center for Metabolic and Degenerative Diseases, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth Houston), Houston, Texas, 77030, USA.
Abstract:
The Hsp70 chaperone system is central in maintaining cellular proteostasis. In eukaryotes, its ATP/ADP nucleotide exchange cycle is stimulated by co-chaperone Hsp110, a divergent Hsp70 superfamily member and a modifier of protein misfolding disorders. Hsp110 chaperone functions and pathway interactions have been extensively characterized biochemically in vitro and genetically in yeast models; however, its physiological roles in metazoans, particularly in the nervous system, are lacking. Here, we showed that the single Hsp110 gene in Drosophila share significant sequence, structural, and splicing-variant similarities with human Hsp110. In Drosophila, Hsp110 is ubiquitously expressed and dispensable for cell proliferation in developing larvae, but is essential for long-term cell survival and nervous system development, including non-autonomous effects on neuronal differentiation and glial cell migration. Furthermore, loss of Hsp110 leads to abnormal accumulation of ubiquitin-positive inclusions in the brain. Lastly, despite being identified as a potent suppressor of protein aggregation and neurotoxicity in neurodegenerative diseases, higher levels of Hsp110 are detrimental in flies. Overexpression of Hsp40, another key co-chaperone of Hsp70, can mimic this effect. However, simultaneous overexpression of both Hsp40 and Hsp110 does not further exacerbate their detrimental effect. Together, these results demonstrate a critical role of Hsp110 in cellular proteostasis, neuronal development, and cell survival in metazoans, and suggest that in vivo, the levels and activities of Hsp110 and Hsp40 co-chaperones need to be properly balanced, and the Hsp70 chaperone network should be considered as a whole when targeted for potential therapeutic purposes to meet the complex pathophysiological demands in multicellular organisms.

